Adjuvant Therapy in Early Stage Endometrial Cancer

Dong-yan WANG,Huai-wu LU,Shao-dan LIN,Zhong-qiu LIN
2015-01-01
Abstract:Despite the good prognosis of early stage endometrial cancer, a part of patients will experience localized disease relapse or distant metastasis following surgery. It is to be solved that how to choose the ideal adjuvant therapy according to the high risk factors. This article conducted a review forⅢphase clinical trials on record during 1990—2013, to evaluate the efficacy and safety of different adjuvant therapies in patient with early stage endometrial cancer. Post-surgical observation is appropriate for low risk patients; brachytherapy may be a better choice for intermediate risk patients; while for high risk patients, external beam radiotherapy is not effective enough in local relapse control and survival rate improvement, and the efficacy of adjuvant chemotherapy is still in study.
What problem does this paper attempt to address?